On domain knowledge, regulatory competence, and the responsible integration of AI in biomedical translation practice
Competence in medical translation cannot be reduced to terminological mastery, however rigorous. It demands something broader, deeper, and in constant evolution.
As a translator specializing in biomedical content, I have come to understand that terminology is one of the three pillars that define true competence in this field — alongside deep domain knowledge and mastery of regulatory frameworks. These dimensions do not operate in isolation: precise terminological command only becomes meaningful when it is grounded in clinical context and aligned with the regulatory environment in which a document will function. In an industry where a mistranslated dosage instruction or a misrendered contraindication can have direct clinical consequences, continuous learning across all three dimensions is not a professional virtue — it is an ethical obligation.
I. Terminology and Domain Knowledge: A Living System
Medical terminology is not a static inventory to be memorized. It is a living system, shaped by evolving clinical practice, emerging pharmacological entities, and shifting regulatory conventions. A translator who treats it as a fixed glossary will, inevitably, produce translations that are lexically correct but contextually inadequate.
True terminological competence in biomedical translation requires sustained engagement with primary sources: peer-reviewed literature, clinical study reports, pharmacovigilance documents, and product monographs. It also requires an understanding of the buyer’s domain — that is, a working knowledge of who commissioned the translation and for what purpose. A Summary of Product Characteristics (SmPC) written for a marketing authorization dossier is not the same document as a Patient Information Leaflet (PIL) intended for lay readers, even when both describe the same medicinal product. The translator must internalize these distinctions and apply them with precision.
Continuous professional development — through medical courses, pharmacology training, clinical terminology workshops, and immersion in the scientific literature — is not optional for a practitioner who intends to operate at this level. It is the baseline.
II. Regulatory Frameworks: Translating Function, Not Just Content
One of the most consequential — and frequently underestimated — dimensions of medical translation competence is regulatory literacy. A translator who does not understand the regulatory function of a document cannot render it faithfully, regardless of their linguistic skill.
In the European context, this means a thorough working knowledge of instruments such as EU Regulation 2017/745 on Medical Devices (EU MDR), which mandates that Instructions for Use (IFU), labelling, and technical documentation be made available in the official languages of all member states where a device is placed on the market. It also means familiarity with the European Medicines Agency’s linguistic review process, which governs the quality and consistency of product information translations submitted under the centralised procedure — including SmPCs, PILs, and labelling annexes subject to Quality Review of Documents (QRD) template requirements.
Failure to understand these frameworks leads to more than stylistic infelicities. It can result in non-compliance findings during notified body reviews, rejection of marketing authorization submissions, or — in the most serious cases — unsafe product documentation reaching healthcare professionals and patients. The translator must therefore understand not only what a document says, but what regulatory weight it carries and what consequences an error entails.
III. Technology and AI: Efficiency Under Vigilance
The integration of artificial intelligence into translation workflows has fundamentally altered the professional landscape — and it demands a clear-eyed assessment that resists both uncritical enthusiasm and reflexive rejection.
There is genuine value in AI-assisted translation tools when applied with expert oversight. Certain tasks that are inherently repetitive and structurally predictable — terminology extraction and management, translation memory leverage, pre-translation of highly standardized regulatory boilerplate — can be meaningfully accelerated through machine assistance. In high-volume regulatory projects involving parallel language versions, these efficiencies are not trivial: they reduce turnaround times and free cognitive resources for the linguistically and conceptually demanding segments that require genuine expert judgment.
However, the application of AI in medical translation without rigorous linguistic post-editing constitutes a professional and ethical risk that cannot be overstated. Machine translation systems, however sophisticated, do not understand clinical context. They do not recognize when a statistically plausible output is pharmacologically absurd, when a syntactic ambiguity in a contraindication section could be interpreted in two clinically opposite ways, or when a terminological choice violates the controlled vocabulary required by a regulatory authority. These failures are invisible to the system that generates them — and potentially invisible to a reviewer who lacks the domain expertise to detect them.
The appropriate model is not automation, but augmentation: AI as a tool that accelerates the mechanical dimensions of the workflow, under the continuous supervision of a translator with the specialized knowledge to validate, correct, and take professional responsibility for the final output.
Conclusion: The Continuous Learning Imperative
Medical translation is, at its core, a knowledge-intensive discipline. Terminological mastery, regulatory literacy, and critical technological judgment are not fixed competencies acquired once and applied indefinitely. They are dynamic, requiring ongoing investment in learning, in professional community, and in honest self-assessment.
For practitioners who embrace that imperative, the field offers something rare: the opportunity to contribute meaningfully to patient safety, to the integrity of scientific communication, and to the global accessibility of medical knowledge. That is a responsibility worth taking seriously.
